Amino Acid, Nitrogen & Heme Metabolism AA

Amino-acid catabolism separates nitrogen handling from carbon-skeleton metabolism. Aminotransferases commonly transfer an amino group to alpha-ketoglutarate, forming glutamate and the corresponding keto acid. Pyridoxal phosphate, derived from vitamin B6, is an important cofactor in these reactions.

Glutamate occupies a central position because it can collect amino nitrogen from many amino acids. Oxidative deamination can release free ammonia, while peripheral tissues also transport nitrogen in less toxic forms such as glutamine or alanine.

Ammonia is neurotoxic at high concentration. Safe transport and hepatic conversion to urea are therefore essential, particularly when amino-acid breakdown increases.

The urea cycle converts nitrogen into urea, a water-soluble compound excreted by kidneys. Reactions are divided between mitochondrial and cytosolic compartments. Carbamoyl phosphate formation initiates mitochondrial nitrogen incorporation; ornithine participates as a carrier within the cycle.

Citrulline moves to the cytosol, where additional reactions incorporate a second nitrogen, eventually forming arginine. Arginase releases urea and regenerates ornithine, which returns to mitochondria.

The cycle consumes energy but protects the organism from ammonia accumulation. Inherited defects can cause hyperammonaemia, and clinical severity depends on the blocked step, residual activity, protein load and catabolic state.

After nitrogen removal, amino-acid carbon skeletons enter central metabolism as pyruvate, acetyl-CoA/acetoacetate or TCA-cycle intermediates. Amino acids yielding substrates capable of supporting net glucose formation are termed glucogenic; those yielding acetyl-CoA or acetoacetate without net glucose production are ketogenic.

This classification becomes important during fasting, illness and inherited metabolic disease. Protein breakdown can provide gluconeogenic carbon, but not every amino acid contributes in the same way.

The biochemical destination also links amino-acid metabolism with TCA-cycle replenishment, ketogenesis and energy production.

Heme synthesis begins with condensation of glycine and succinyl-CoA in mitochondria, followed by a series of cytosolic and mitochondrial reactions that construct the porphyrin ring and insert iron. Regulation is especially important because free intermediates can be biologically active or toxic.

Heme is incorporated into haemoglobin, myoglobin, cytochromes and other proteins. Defects in specific synthetic enzymes can cause accumulation of characteristic precursors, producing porphyrias with neurological, abdominal or photosensitive manifestations depending on the pathway position.

Lead can interfere with selected enzymes of heme synthesis, illustrating how toxic exposure can create a biochemical phenotype by blocking pathway reactions.

Senescent red cells are broken down by macrophage systems. Heme is converted to biliverdin and then unconjugated bilirubin. Because unconjugated bilirubin is poorly water soluble, it travels in plasma bound to albumin.

Hepatocytes take up bilirubin and conjugate it with glucuronic acid, making it more water soluble. Conjugated bilirubin is secreted into bile and reaches intestine, where microbial metabolism produces downstream pigments and compounds, some of which are reabsorbed.

Prehepatic overproduction, impaired hepatic uptake/conjugation and cholestatic or obstructive failure of excretion produce different bilirubin patterns. Mechanism should therefore drive interpretation of jaundice.

Amino acids serve as building blocks for proteins and as precursors for many biologically active molecules. Unlike triacylglycerol or glycogen, the body has no dedicated storage polymer for excess amino acids. Amino groups must therefore be handled safely while carbon skeletons enter energy, glucose or lipid pathways according to metabolic state.

Transamination transfers amino groups between amino acids and keto acids, often funnelling nitrogen toward glutamate. Oxidative processes can release ammonia, which is toxic at high concentrations, especially to the nervous system. The liver converts much nitrogen to urea through the urea cycle, allowing renal excretion in a less toxic form.

Amino-acid carbon skeletons are classified by whether their degradation yields precursors capable of supporting net glucose production, ketone-related products, or both. Inherited enzyme defects can cause accumulation of substrates, deficiency of products or diversion into alternative metabolites.

Heme synthesis produces the prosthetic group used in haemoglobin and other heme proteins. Heme degradation generates bilirubin, which must be transported, conjugated by liver and excreted through bile. Disturbance at different steps produces different biochemical patterns of jaundice.

Mechanism map: protein/amino acid → nitrogen transfer → ammonia handling → urea → renal excretion, while carbon skeleton → central metabolism. For bilirubin: heme breakdown → unconjugated bilirubin transport → hepatic uptake/conjugation → biliary excretion → intestinal products.

Clinical integration includes hyperammonaemia, urea-cycle defects, aminoacidopathies, porphyrias and jaundice. Pattern recognition should be derived from the blocked step rather than memorized without mechanism.

Common confusion: transamination usually transfers an amino group; it does not itself mean that free ammonia is always released. Unconjugated and conjugated bilirubin differ in transport and water solubility.